Solid-State Nuclear Magnetic Resonance Identifies Abnormal Calcium Phosphate Formation in Diseased Bones

Area of Science:

• Biomaterials Science
• Nanotechnology
• Orthopedics

Background:

• Bone strength is determined by nanoscale calcium phosphate (CaP) crystallites, primarily hydroxyl apatite (HA) and amorphous calcium phosphate (ACP).
• Bone formation and resorption processes sculpt these CaP structures, influencing overall bone integrity.
• Understanding CaP nanostructure is crucial for diagnosing and treating bone diseases.

Purpose of the Study:

• To investigate nanoscopic structural changes in CaP crystallites using solid-state nuclear magnetic resonance (SSNMR).
• To quantify mineral crystallinity and the ratio of ACP to HA in various bone disease models.
• To correlate CaP nanostructural alterations with specific bone pathologies.

Main Methods:

• Utilized one- and two-dimensional 1H-31P solid-state nuclear magnetic resonance (SSNMR).
• Deduced quantitative measures from 31P signal linewidth and ACP to HA ratio.
• Analyzed bone samples from murine models of osteopetrosis and osteoporosis, and human samples with osteoporosis and osteoarthritis.

Main Results:

• Osteopetrotic bones showed increased amorphous calcium phosphate (ACP) content, linked to defective osteoclast resorption.
• Osteoporotic bones exhibited increased mineral crystallinity, associated with overactive osteoclast resorption.
• Osteoarthritis sclerotic bones displayed similar pathological CaP characteristics to osteopetrotic bones.

Conclusions:

• Osteoclast-related bone diseases induce abnormal CaP crystallite formation, affecting nanoscopic bone structure.
• SSNMR quantitative measurements offer a novel perspective on bone disease pathology at the nanoscale.
• These findings highlight the link between macroscopic bone density changes and microscopic CaP alterations in diseases.